Immunogenicity and safety of a group B Streptococcus vaccine (GBS-AlpN) in pregnant women and their infants: a phase 2, multicentre, observer-blind, randomised, placebo-controlled study
Paul T. Heath, Ntokozo Zuma-Gwala, Rikke Bek Helmig, Elizea Horne, Anette Kjærbye-Thygesen, Mie Korslund Wiinblad Crusell, Maphoshane Nchabeleng, Renate Strehlau, Mohammed R. Khalil, Christine E. Jones, Jorne Biccler, Jeannett Dimsits*, Bengt Johannsson-Lindbom, Lidia Oostvogels, Shabir A. Madhi, MVX0004 study group
Dive into the research topics of 'Immunogenicity and safety of a group B Streptococcus vaccine (GBS-AlpN) in pregnant women and their infants: a phase 2, multicentre, observer-blind, randomised, placebo-controlled study'. Together they form a unique fingerprint.
Keyphrases
Medicine and Dentistry
Pharmacology, Toxicology and Pharmaceutical Science